Evidence map›Paper›PMID 40620843›Full record

Observational studyJournal of diabetes research2025

Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational Study.

Ayami Kajiwara-Morita, Kentaro Oniki, Akira Yoshida, Noboru Kurinami, Tomoko Suzuki, Fumio Miyamoto, Kunio Hieshima, Seigo Sugiyama, Keizo Kajiwara, Katsunori Jinnouchi and 2 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ayami Kajiwara-MoritaDivision of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0009-0000-9309-2458
Kentaro OnikiDivision of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-5926-7151
Akira YoshidaJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Noboru KurinamiJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Tomoko SuzukiJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Fumio MiyamotoJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Kunio HieshimaJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Seigo SugiyamaJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Keizo KajiwaraJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Katsunori JinnouchiJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.
Junji SaruwatariDivision of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0001-6266-1347
Hideaki JinnouchiJinnouchi Hospital, Diabetes Care Center, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-7391-7966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlbuminuriaAnemiaDiabetes Mellitus, Type 2Diabetic NephropathiesKidneyRenal Insufficiency, ChronicSodium-Glucose Transporter 2 InhibitorsAgedFemaleGlomerular Filtration RateHemoglobinsHumansLongitudinal StudiesMaleMiddle AgedRetrospective StudiesHemoglobinsSodium-Glucose Transporter 2 Inhibitors

Identifiers

PMID40620843
PMCPMC12228570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.